DIA 2020 Global Annual Meeting

Amid the wake of COVID-19, sites are increasingly proving to be inaccessible for patients, site staff, and/or site monitors, and regulators halt inspections, while the biopharma industry faces many new challenges to ensure patient safety. Life science stakeholders must come together to join the global effort of driving healthcare forward. This talk discusses how digitally connecting siloed people, applications, and departments create a seamless trial management experience in a virtual or hybrid trial model with eConsent, remote monitoring, and enhanced randomization.